Hypoxia in renal disease with proteinuria and/or glomerular hypertension

American Journal of Pathology

Volumn 165, Issue 6, 2004, Pages 1979-1992

  Tanaka, Tetsuhiro ^a   Miyata, Toshio ^b   Inagi, Reiko ^b   Fujita, Toshiro ^a   Nangaku, Masaomi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; PUROMYCIN AMINONUCLEOSIDE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC ANALYSIS; GLOMERULOPATHY; HYPOXIA; KIDNEY DISEASE; MALE; MICROSCOPY; NEPHROTIC SYNDROME; NICK END LABELING; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; RAT; RENOVASCULAR HYPERTENSION; TRANSGENE;

EID: 9644291798     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63249-X     Document Type: Article

References (46)

1. Wiener CM, Booth G, Semenza GL: In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 1996, 225:485-488
2. Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999, 15:551-578
3. Semenza GL: HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000, 88:1474-1480
4. Wenger RH: Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol 2000, 203:1253-1263
5. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292:468-472
6. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin Jr WG: HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001, 292:464-468
7. Yu F, White SB, Zhao Q, Lee FS: HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 2001, 98:9630-9635
8. Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ, Harris AL: Targeting gene expression to hypoxic tumor cells. Nat Med 1997, 3:515-520
9. Shibata T, Giaccia AJ, Brown JM: Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther 2000, 7:493-498
10. Prchal JT: Delivery on demand - a new era of gene therapy? N Engl J Med 2003, 348:1282-1283
11. Binley K, Askham Z, Iqball S, Spearman H, Martin L, de Alwis M, Thrasher AJ, Ali RR, Maxwell PH, Kingsman S, Naylor S: Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. Blood 2002, 100:2406-2413
12. Durand RE, Raleigh JA: Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res 1998, 58:3547-3550
13. Levy AP, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995, 270:13333-13340
14. Jacobson HR: Chronic renal failure: pathophysiology. Lancet 1991, 338:419-423
15. Bohle A, Kressel G, Muller CA, Muller GA: The pathogenesis of chronic renal failure. Pathol Res Pract 1989, 185:421-440
16. Fine LG, Bandyopadhay D, Norman JT: Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int Suppl 2000, 75:S22-S26
17. Fine LG, Orphanides C, Norman JT: Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 1998, 65:S74-S78
18. Ingelfinger JR, Jung F, Diamant D, Haveran L, Lee E, Brem A, Tang SS: Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol 1999, 276:F218-F227
19. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, Schaffner W: A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985, 41:521-530
20. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001, 12:1434-1447
21. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR: Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 2000, 48:285-296
22. Chou SC, Flood PM, Raleigh JA: Marking hypoxic cells for complement and cytotoxic T lymphocyte-mediated lysis: using pimonidazole. Br J Cancer Suppl 1996, 27:3213-3216
23. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997, 38:285-289
24. Hockel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, Knapstein PG, Vaupel P: Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993, 26:45-50
25. Nordsmark M, Overgaard M, Overgaard J: Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996, 41:31-39
26. Shima DT, Deutsch U, D'Amore PA: Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995, 370:203-208
27. Levy AP, Levy NS, Goldberg MA: Post-transcripitonal regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996, 271:2746-2753
28. Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, Plate KH: Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 1997, 57:3860-3864
29. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, Seed B: Tumor induction of VEGF promoter activity in stromal cells. Cell 1998, 94:715-725
30. Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N: Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001, 159:599-608
31. Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ: Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 2000, 58:2390-2399
32. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002, 13:806-816
33. Shao J, Miyata T, Yamada K, Hanafusa N, Wada T, Gordon KL, Inagi R, Kurokawa K, Fujita T, Johnson RJ, Nangaku M: Protective role of nitric oxide in a model of thrombotic microangiopathy in rats. J Am Soc Nephrol 2001, 12:2088-2097
34. Kang DH, Nakagawa T, Feng L, Johnson RJ: Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 2002, 161:239-248
35. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001, 12:1448-1457
36. Priyadarshi A, Periyasamy S, Burke TJ, Britton SL, Malhotra D, Shapiro JI: Effects of reduction of renal mass on renal oxygen tension and erythropoietin production in the rat. Kidney Int 2002, 61:542-546
37. Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM, Venkatachalam MA: Role of hypoxia-induced Bax translocation and cytochrome C release in reoxygenation injury. Oncogene 1998, 17:3401-3415
38. Tanaka T, Hanafusa N, Ingelfinger JR, Ohse T, Fujita T, Nangaku M: Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. Biochem Biophys Res Commun 2003, 309:222-231
39. Eddy AA: Proteinuria and interstitial injury. Nephrol Dial Transplant 2004, 19:277-281
40. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002, 13:1721-1732
41. Rosenberger C, Griethe W, Gruber G, Wiesener M, Frei U, Bachmann S, Eckardt KU: Cellular responses to hypoxia after renal segmental infarction. Kidney Int 2003, 64:874-886
42. Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, Fujita T, Nangaku M: Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003, 14:1825-1832
43. Tan CC, Eckardt KU, Ratcliffe PJ: Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int 1991, 40:69-76
44. Eckardt KU: Erythropoietin: oxygen-dependent control of erythropoiesis and its failure in renal disease. Nephron 1994, 67:7-23
45. Manotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, Kurokawa K, Fujita T, Nangaku M: Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 2004, 15:1277-1288
46. Matsumoto M, Tanaka T, Yamamoto T, Noiri E, Miyata T, Inagi R, Fujita T, Nangaku M: Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 2004, 15:1574-1581